14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 2 days ( -7.57 % )
Last Price $1.99 7.57 %
High/ Low $1.86 - $2.04 26.34%
Chg 7 Days 23.60 % $1.61 $1.99
Chg 30 Days 2.58 % $1.94 $1.99
Chg 12 mos -66.04 % $5.86 $1.99
Trend - 3 mos -36.44 % Width: 48.02 %
Trend - 12 mos -46.39 % Width: 144.84 %
Pred. range - 3 mos $0.85 - $1.26 -57.06 % - -36.44 %
Pred. range - 12 mos $0.752 - $1.84 -62.19 % - -7.44 %
Short MA avg 3 mos Buy Apr 25, 2024 - 7 days
Long MA avg 3 mos Buy May 01, 2024 - 3 days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy May 01, 2024 - 3 days
Long MA avg 12 mos Buy Jan 09, 2024 - 81 days
Short/Long MA avg 12 mos Sell Jun 09, 2023 - 227 days
Pivot Short Buy Apr 22, 2024 - 10 days
Bollinger Buy Mar 08, 2024 - 40 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Ocuphire Pharma, Inc.

Ocuphire Pharma. Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical trial for dim light or night vision disturbances; and Phase 2b clinical trial for pharmacologically induc... OCUP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT